2.1.1.179 additional information analysis of sequence–function relationships of Sgm MTase by limited proteolysis and site-directed and random mutagenesis 702415 2.1.1.179 additional information construction of a series of in-frame knockout and knock-in mutants of Escherichia coli, corresponding to the genotypes rsmF+, DELTArsmF, rsmF+ rmtC+, and DELTArsmF rmtC+, mutant strain growth kinetics, overview -, 718596 2.1.1.179 H54A inactive. Mutation dos not impact 30S binding affinity. Mutant strain is sensitive to kanamycin and gentamicin 757224 2.1.1.179 H54E inactive. Mutation dos not impact 30S binding affinity. Mutant strain is sensitive to kanamycin and gentamicin 757224 2.1.1.179 E205A mutant retains S-adenosyl-L-methionine binding 704280 2.1.1.179 E267A mutant retains S-adenosyl-L-methionine binding 704280 2.1.1.179 K199A mutant retains S-adenosyl-L-methionine binding 704280 2.1.1.179 R236A mutant retains S-adenosyl-L-methionine binding 704280 2.1.1.179 D156A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 D158A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 D182A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 E205A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 E267A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 G135A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 K199A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 K54A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 R108A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 R187S mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 R236A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 R433A mutant with drastically increased sensitivity to kanamycin 702415 2.1.1.179 R187S/G212S mutant with strongly reduced activity 702415 2.1.1.179 K20E mutation eliminates 30S binding affinity, mutant strain is sensitive to kanamycin and gentamicin 757224 2.1.1.179 R68E mutation reduces 30S binding affinity about 11-13fold, resistance to kanamycin and gentamcin is reduced 757224 2.1.1.179 R50E mutation reduces 30S binding affinity about 11-13fold. Mutant strain is sensitive to kanamycin and gentamicin 757224 2.1.1.179 K72E mutation reduces 30S binding affinity about 5fold, resistance to kanamycin and gentamcin is reduced 757224 2.1.1.179 D156A no binding of S-adenosyl-L-methionine 704280 2.1.1.179 D182A no binding of S-adenosyl-L-methionine 704280 2.1.1.179 G135A no binding of S-adenosyl-L-methionine 704280 2.1.1.179 additional information replacement of the RmtC loop with four Ala residues (Loop237-246 ->A4) ablates the enzyme's ability to confer resistance to kanamycin and gentamicin. Conserved C-terminal domain residues surrounding the SAM-binding pocket are functionally critical but do not contribute to 30S binding affinity 757224 2.1.1.179 H50A tobramycin MIC is drastically reduced compared to wild-type enzyme 712741 2.1.1.179 R181A tobramycin MIC is drastically reduced compared to wild-type enzyme 712741 2.1.1.179 K174A tobramycin MIC is drastically reduced compared to wild-type enzyme. 0.7% of the methylation activity compared to wild-type enzyme 712741 2.1.1.179 E182A tobramycin MIC is identical with that of wild-type RmtB 712741 2.1.1.179 R17A tobramycin MIC is identical with that of wild-type RmtB 712741 2.1.1.179 R48A tobramycin MIC is identical with that of wild-type RmtB 712741 2.1.1.179 Y56F tobramycin MIC is identical with that of wild-type RmtB 712741 2.1.1.179 S83A tobramycin MIC is identical with that of wild-type RmtB. 18% of the methylation activity compared to wild-type enzyme 712741 2.1.1.179 K14A tobramycin MIC is identical with that of wild-type RmtB. 36% of the methylation activity compared to wild-type enzyme 712741 2.1.1.179 H81A tobramycin MIC is identical with that of wild-type RmtB. No change in methylation activity compared to wild-type enzyme 712741